To download the program click here

ISSFAL 2010 Maastricht

Lipids in Metabolic Health and Disease

Conference Program
 

TRACKS:

1.   Lipids and Health                                                                                                                          

2.   Biochemistry of Lipids                                                                                                                 

3.   Lipids and Nutrition                                                                                                                     


Monday May 31

 

08.30-10.00

 
08.30-09.15

09.15-10.00

Plenary: Diet and Nutrition: Maternal and infant nutrition
Chairs: Renate de Groot, Susan Carlson

(PL 5) FA status and supplementation (Gerard Hornstra, Maastricht, The Netherlands)

(PL6) Consequences of FA supplementation (Ingrid Helland, Oslo, Norway)
 

10.00-10.30

Break

10.30-12.00

Concurrent sessions 7-9

 

7. Metabolic syndrome – obesity/diabetes

Chairs: Ellen Blaak, Sebastiano Banni

 

8. Lipid signaling/Lipid mediators

Chairs: Jan Kopecky, Robert Schwenk

 

9. Maternal and Infant nutrition II - Mental development

Chairs: Peter Howe, Renate de Groot

10.30 – 11.00

Matthijs Hesselink (Netherlands)

Ectopic fat storage and insulin sensitivity

Jan Kopecky (Czech republic)

Multiple mechanisms of action of n-3 fatty acids on metabolism – possible impact for the treatment of metabolic syndrome
 

Karen Simmer (Australia)

LCPUFA supplementation and infant development

11.00 – 11.15

A. Alvheim (Norway)

Dietary linoleic acid promotes hyperactive hepatic 2-arachidonoyl-glycerol and contributes to diet-induced obesity

P. Chen (France)

Inhibition of platelet aggregation by a new class of fatty acid oxygenated products called poxotrins, including a protectin d1 isomer

U. Ramakrishnan (USA)

Effect of prenatal supplementation with docosahexanoic acid on child size and development at 18 mo: randomized placebo-controlled trial in Mexico

 

11.15 – 11.30

P. Flachs (Czech republic)

N-3 fatty acids augment beneficial effects of mild calorie restriction in mice fed high-fat diet - role of sirt1

T. Hornemann (Switzerland)

Accumulation of two atypical sphingolipids underlies the pathology in  hereditary sensory neuropathy hsan1

D. Hoffman (USA)

Cognitive function in 18-month old term infants of the diamond study: a dha dose-response randomized, controlled clinical trial
 

11.30 – 11.45

E. Newberry (USA)

Reduced hepatic and serum fatty acid amides in l-fabp-/- mice alter feeding behavior and protect against obesity

G. Dramane (France)

Identification of different isoformes of pla2 in mouse cd36 positive lipid gustatory cells: implication in calcium signalling

T. Karlsson (Sweden)

LCPUFA supplemented to mothers during pregnancy and breast-feeding improves cognitive performance in their children four years later--an RCT study
 

11.45 – 12.00

P. Nunes (Netherlands)

Creatine depletion hampers glucose and lipid metabolisms of AGAT-/- mice

 

V. Stone (UK)

The cytoprotective actions of oleoylethanolamide in pancreatic beta-cells require fatty acid amide hydrolase activity and are not mediated via GPR119 
 

C. Milte (Australia)

Effects of EPA versus DHA on literacy and behaviour in children with adhd and learning difficulties 

 



12.00-14.00

 

Lunch with Poster Session 2
 

14.00-15.30

Concurrent sessions 10-12

 

10. Brain function II – Other aspects

Chairs: Olga Schiepers, Hee-Yong Kim

 

11. Cardio biochemistry

Chairs: Peter McLennan, Vera Schrauwen

 

12. Standardizing protocol

Chairs: Clemens von Schacky, Simon Dyall

14.00 – 14.15

N. Osumi (Japan)

The effects of arachidonic acid and docosahexaenoic acid on neural stem/progenitor cells

P. McLennan (Australia)

Fish oil feeding induces nutritional preconditioning in the rat heart by upregulating endogenous antioxidants and reducing oxidative damage
 

Simon Dyall (UK)

Methodological issues and inconsistencies in omega-3 fatty acid research

14.15 – 14.30

B. Levant (USA)

Effects of dietary n-3 fatty acids and brain dha content on activity and response to novelty in the developing rat

 

M. Bernard (France)

The cardioprotective effect of docosahexaenoic acid occurs through myocardial physiological and metabolic changes in rat heart on digitalis drug treatment
 

14.30 – 14.45

R. Gow (UK)

The relationship between measures of depression, anxiety and anger/disruptive behaviour and omega-3/6 fatty acids in adolescents with and without ADHD
 

W. Schunck (Germany)

Effect of dietary omega-3 fatty acids on the endogenous cyp eicosanoid profile

B. de Roos (UK)

Participating in a controlled dietary fat study, rather than the nature of intervention, regulates the plasma proteome in healthy men

14.45 – 15.00

Y. Matsuoka (Japan)

Omega-3 fatty acids for secondary prevention of  posttraumatic stress disorder following accidental injury: an open-label pilot study
 

L. Steinbusch (Netherlands)

Balanced substrate supply is essential for cardiac protection of the compromised heart

A. Patterson (Canada)

Long term adherence following advice to increase eicosapentaenoic and docosahexaenoic acid intakes using different dietary strategies

15.00 – 15.15

Y. Kiso (Japan)

Arachidonic acid (ARA)-enriched triacylglycerol supplementation was more effective in improving cognitive function of elderly men with low serum ARA level

D. Abdurrachim (Netherlands)

Myocardial lipid accumulation and diabetic cardiomyopathy status studied in vivo in a diabetic mouse model using 1H-MRS and MRI
 

T. Gilhooly (UK)

Percentage of n-3 HUFA: a simple measure of HUFA balance

 

15.15 – 15.30

O. van de Rest (Netherlands)

Fish fatty acids and mental health in older people

C. van den Brom (Netherlands)

Myocardial sphingolipid metabolism in zucker diabetic fatty rats

F. Marangoni (Italy)

Whole blood fatty acids, not only n-3, are associated with dietary habits and cardiovascular risk factors in an Italian population
 

15.30-16.00

Break

16.00-17.30

 
16.00-16.45

16.45-17.30

Plenary: Lipids and Health 2: brain function
Chairs: Mehar Manku, Ray Rice

(PL 7) Mechanisms of altered brain function and aging (Stanley Rapoport, Bethesda, USA)

(PL 8) DHA and cognitive decline during aging (Stephen Cunnane, Quebec, Canada)
 

19.00 – 23.00

Issfal Dinner Debate: 'Healthy fats for healthy hearts'
 (held in the Bonbonniere, Maastricht, limited attendance)                    

(Sponsored by Wyeth)

 

Note for Concurrent Sessions:
The Organizing Committee reserves the right to change the title of the concurrent session depending on the number and quality of submitted abstracts.

 

 

Platinum Sponsor:

Gold Sponsor:

Silver Sponsor:

                           

                                       

                             
 

             

Welcome Reception and
Gala Dinner sponsor:

Delegate bag Sponsors:

Delegate lanyards:



Contributors: